Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Artificial bezoar (Rengong Niuhuang) is a multi-component synthetic medicinal substance designed to replicate the therapeutic properties of natural ox gallstones (Calculus Bovis). Developed and manufactured by Guangzhou Hanpu Pharmaceutical, it is a standardized mixture typically composed of bovine bile powder, cholic acid, hyodeoxycholic acid, taurine, bilirubin, and cholesterol. It is widely utilized in Traditional Chinese Medicine (TCM) for its potent antipyretic, anti-inflammatory, and sedative effects. It is primarily indicated for the treatment of conditions characterized by excessive heat, such as high fever, sore throat, mouth sores, and convulsions. The substance is approved in China and serves as a critical active pharmaceutical ingredient in numerous proprietary Chinese medicines.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on artificial bezoar.